Cargando…
Angiogenesis-Related Gene Expression Profile with Independent Prognostic Value in Advanced Ovarian Carcinoma
BACKGROUND: Ovarian carcinoma is the most important cause of gynecological cancer-related mortality in Western societies. Despite the improved median overall survival in patients receiving chemotherapy regimens such as paclitaxel and carboplatin combination, relapse still occurs in most advanced dis...
Autores principales: | Mendiola, Marta, Barriuso, Jorge, Redondo, Andrés, Mariño-Enríquez, Adrián, Madero, Rosario, Espinosa, Enrique, Vara, Juan Ángel Fresno, Sánchez-Navarro, Iker, Hernández-Cortes, Ginés, Zamora, Pilar, Pérez-Fernández, Elia, Miguel-Martín, María, Suárez, Asunción, Palacios, José, González-Barón, Manuel, Hardisson, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605264/ https://www.ncbi.nlm.nih.gov/pubmed/19112514 http://dx.doi.org/10.1371/journal.pone.0004051 |
Ejemplares similares
-
Comparison of Prognostic Gene Profiles Using qRT-PCR in Paraffin Samples: A Retrospective Study in Patients with Early Breast Cancer
por: Espinosa, Enrique, et al.
Publicado: (2009) -
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer
por: Sánchez-Navarro, Iker, et al.
Publicado: (2010) -
Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel
por: Mendiola, Marta, et al.
Publicado: (2016) -
MALDI Profiling of Human Lung Cancer Subtypes
por: Gámez-Pozo, Angelo, et al.
Publicado: (2009) -
Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer
por: Redondo, Andrés, et al.
Publicado: (2014)